• Je něco špatně v tomto záznamu ?

The molecular features of chronic lung allograft dysfunction in lung transplant airway mucosa

K. Halloran, M. Mackova, MD. Parkes, A. Hirji, J. Weinkauf, IL. Timofte, GI. Snell, GP. Westall, R. Lischke, A. Zajacova, J. Havlin, R. Hachem, D. Kreisel, D. Levine, B. Kubisa, M. Piotrowska, S. Juvet, S. Keshavjee, P. Jaksch, W. Klepetko, PF. Halloran

. 2022 ; 41 (12) : 1689-1699. [pub] 20220827

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032411

BACKGROUND: Many lung transplants fail due to chronic lung allograft dysfunction (CLAD). We recently showed that transbronchial biopsies (TBBs) from CLAD patients manifest severe parenchymal injury and dedifferentiation, distinct from time-dependent changes. The present study explored time-selective and CLAD-selective transcripts in mucosal biopsies from the third bronchial bifurcation (3BMBs), compared to those in TBBs. METHODS: We used genome-wide microarray measurements in 324 3BMBs to identify CLAD-selective changes as well as time-dependent changes and develop a CLAD classifier. CLAD-selective transcripts were identified with linear models for microarray data (limma) and were used to build an ensemble of 12 classifiers to predict CLAD. Hazard models and random forests were then used to predict the risk of graft loss using the CLAD classifier, transcript sets associated with rejection, injury, and time. RESULTS: T cell-mediated rejection and donor-specific antibody were increased in CLAD 3BMBs but most had no rejection. Like TBBs, 3BMBs showed a time-dependent increase in transcripts expressed in inflammatory cells that was not associated with CLAD or survival. Also like TBBs, the CLAD-selective transcripts in 3BMBs reflected severe parenchymal injury and dedifferentiation, not inflammation or rejection. While 3BMBs and TBBs did not overlap in their top 20 CLAD-selective transcripts, many CLAD-selective transcripts were significantly increased in both for example LOXL1, an enzyme controlling matrix remodeling. In Cox models for one-year survival, the 3BMB CLAD-selective transcripts and CLAD classifier predicted graft loss and correlated with CLAD stage. Many 3BMB CLAD-selective transcripts were also increased by injury in kidney transplants and correlated with decreased kidney survival, including LOXL1. CONCLUSIONS: Mucosal and transbronchial biopsies from CLAD patients reveal a diffuse molecular injury and dedifferentiation state that impacts prognosis and correlates with the physiologic disturbances. CLAD state in lung transplants shares features with failing kidney transplants, indicating elements shared by the injury responses of distressed organs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032411
003      
CZ-PrNML
005      
20230131151251.0
007      
ta
008      
230120s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.healun.2022.08.014 $2 doi
035    __
$a (PubMed)36163162
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Halloran, Kieran $u University of Alberta, Edmonton, Alberta, Canada
245    14
$a The molecular features of chronic lung allograft dysfunction in lung transplant airway mucosa / $c K. Halloran, M. Mackova, MD. Parkes, A. Hirji, J. Weinkauf, IL. Timofte, GI. Snell, GP. Westall, R. Lischke, A. Zajacova, J. Havlin, R. Hachem, D. Kreisel, D. Levine, B. Kubisa, M. Piotrowska, S. Juvet, S. Keshavjee, P. Jaksch, W. Klepetko, PF. Halloran
520    9_
$a BACKGROUND: Many lung transplants fail due to chronic lung allograft dysfunction (CLAD). We recently showed that transbronchial biopsies (TBBs) from CLAD patients manifest severe parenchymal injury and dedifferentiation, distinct from time-dependent changes. The present study explored time-selective and CLAD-selective transcripts in mucosal biopsies from the third bronchial bifurcation (3BMBs), compared to those in TBBs. METHODS: We used genome-wide microarray measurements in 324 3BMBs to identify CLAD-selective changes as well as time-dependent changes and develop a CLAD classifier. CLAD-selective transcripts were identified with linear models for microarray data (limma) and were used to build an ensemble of 12 classifiers to predict CLAD. Hazard models and random forests were then used to predict the risk of graft loss using the CLAD classifier, transcript sets associated with rejection, injury, and time. RESULTS: T cell-mediated rejection and donor-specific antibody were increased in CLAD 3BMBs but most had no rejection. Like TBBs, 3BMBs showed a time-dependent increase in transcripts expressed in inflammatory cells that was not associated with CLAD or survival. Also like TBBs, the CLAD-selective transcripts in 3BMBs reflected severe parenchymal injury and dedifferentiation, not inflammation or rejection. While 3BMBs and TBBs did not overlap in their top 20 CLAD-selective transcripts, many CLAD-selective transcripts were significantly increased in both for example LOXL1, an enzyme controlling matrix remodeling. In Cox models for one-year survival, the 3BMB CLAD-selective transcripts and CLAD classifier predicted graft loss and correlated with CLAD stage. Many 3BMB CLAD-selective transcripts were also increased by injury in kidney transplants and correlated with decreased kidney survival, including LOXL1. CONCLUSIONS: Mucosal and transbronchial biopsies from CLAD patients reveal a diffuse molecular injury and dedifferentiation state that impacts prognosis and correlates with the physiologic disturbances. CLAD state in lung transplants shares features with failing kidney transplants, indicating elements shared by the injury responses of distressed organs.
650    _2
$a lidé $7 D006801
650    12
$a rejekce štěpu $x genetika $7 D006084
650    _2
$a retrospektivní studie $7 D012189
650    12
$a transplantace plic $7 D016040
650    _2
$a plíce $7 D008168
650    _2
$a alografty $7 D064591
650    _2
$a sliznice $7 D009092
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mackova, Martina $u University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Parkes, Michael D $u University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Hirji, Alim $u University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Weinkauf, Justin $u University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Timofte, Irina L $u University of Maryland, Baltimore, Maryland
700    1_
$a Snell, Greg I $u Alfred Hospital Lung Transplant Service, Melbourne, Victoria, Australia
700    1_
$a Westall, Glen P $u Alfred Hospital Lung Transplant Service, Melbourne, Victoria, Australia
700    1_
$a Lischke, Robert $u University Hospital Motol, Prague, Czech Republic
700    1_
$a Zajacova, Andrea $u University Hospital Motol, Prague, Czech Republic
700    1_
$a Havlin, Jan $u University Hospital Motol, Prague, Czech Republic
700    1_
$a Hachem, Ramsey $u Washington University in St Louis, St. Louis, Missouri
700    1_
$a Kreisel, Daniel $u Washington University in St Louis, St. Louis, Missouri
700    1_
$a Levine, Deborah $u University of Texas at San Antonio, San Antonio, Texas
700    1_
$a Kubisa, Bartosz $u Pomeranian Medical University, Szczecin, Poland
700    1_
$a Piotrowska, Maria $u Pomeranian Medical University, Szczecin, Poland
700    1_
$a Juvet, Stephen $u Toronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada
700    1_
$a Keshavjee, Shaf $u Toronto Lung Transplant Program, University Health Network, Toronto, Ontario, Canada
700    1_
$a Jaksch, Peter $u Medical University of Vienna, Vienna, Austria
700    1_
$a Klepetko, Walter $u Medical University of Vienna, Vienna, Austria
700    1_
$a Halloran, Philip F $u University of Alberta, Edmonton, Alberta, Canada. Electronic address: phallora@ualberta.ca
773    0_
$w MED00002704 $t The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation $x 1557-3117 $g Roč. 41, č. 12 (2022), s. 1689-1699
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36163162 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151247 $b ABA008
999    __
$a ok $b bmc $g 1891272 $s 1183746
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 41 $c 12 $d 1689-1699 $e 20220827 $i 1557-3117 $m The Journal of heart and lung transplantation $n J Heart Lung Transplant $x MED00002704
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace